Close

Analyst Ratings for Kintara Therapeutics, Inc (KTRA) [Neutrals]

KTRA Rating Summary

  |   Expand Research on KTRA
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: N/A
Rating Score: 5 / 10   Percentile Rank: 53%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
10/31/2023 Maxim Group Jason McCarthy Downgrade Hold
(Buy)
N/A
(N/A)
3.76
(0.12)
-96.81% Details
5/16/2022 Dawson James Jason H. Kolbert Downgrade Neutral
(Buy)
1.00
(3.00)
0.19
(0.12)
-36.84% Details